u-62840 and Neurofibromatosis-1

u-62840 has been researched along with Neurofibromatosis-1* in 1 studies

Other Studies

1 other study(ies) available for u-62840 and Neurofibromatosis-1

ArticleYear
Atrial septostomy and disease targeting therapy in pulmonary hypertension secondary to neurofibromatosis.
    BMC pulmonary medicine, 2016, 12-07, Volume: 16, Issue:1

    Neurofibromatosis type 1 (NF1) is a rare multisystem genetic disorder. During the course of the disease it can be rarely complicated with pulmonary hypertension (PH) which confers a dismal prognosis.. We describe the case of a 57-year-old female patient with NF1 complicated by severe precapillary PH despite dual disease-specific oral combination therapy. The patient was treated with initial atrial septostomy followed by administration of high-dose subcutaneous treprostinil with a favorable medium-term clinical and hemodynamic response.. PH secondary to NF1 may be successfully treated with the combination of atrial septostomy and PH targeted therapy in selected patients.

    Topics: Antihypertensive Agents; Cardiac Surgical Procedures; Echocardiography; Epoprostenol; Female; Heart Atria; Hemodynamics; Humans; Hypertension, Pulmonary; Injections, Subcutaneous; Middle Aged; Neurofibromatosis 1; Prognosis; Ventricular Remodeling

2016